Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (FRA:08HH)

FRA:08HH Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	8,455	7,907	7,858	11,792	15,760	15,751
Market Cap Growth	2.69%	0.61%	-33.36%	-25.18%	0.06%	89.10%
Enterprise Value	12,892	12,014	11,384	14,938	18,686	18,497
Last Close Price	2.27	1.67	1.83	2.91	3.34	3.35
PE Ratio	21.52	21.57	25.82	23.30	24.08	34.34
PS Ratio	1.79	1.46	1.49	1.98	2.92	4.15
PB Ratio	1.16	1.00	1.09	1.61	2.35	2.74
P/TBV Ratio	3.07	2.73	2.89	3.99	5.83	6.40
P/FCF Ratio	220.48	894.58	-	-	-	-
P/OCF Ratio	14.50	13.35	18.04	20.61	28.92	48.76
EV/Sales Ratio	2.65	2.21	2.15	2.51	3.46	4.87
EV/EBITDA Ratio	19.75	16.47	22.98	19.87	32.27	36.18
EV/EBIT Ratio	42.59	30.53	75.34	32.19	53.22	56.42
EV/FCF Ratio	336.16	1359.25	-	-	-	-
Debt / Equity Ratio	0.60	0.60	0.62	0.56	0.53	0.52
Debt / EBITDA Ratio	6.93	6.07	8.44	5.25	5.86	5.63
Debt / FCF Ratio	114.65	539.31	-	-	-	-
Asset Turnover	0.34	0.36	0.38	0.44	0.44	0.38
Inventory Turnover	2.91	2.90	3.01	3.77	3.82	3.03
Quick Ratio	0.66	0.68	0.73	0.78	0.75	0.71
Current Ratio	0.92	0.92	1.00	1.06	1.04	1.01
Return on Equity (ROE)	6.75%	6.03%	5.23%	7.70%	10.55%	9.25%
Return on Assets (ROA)	1.32%	1.61%	0.67%	2.13%	1.79%	2.05%
Return on Capital (ROIC)	1.60%	1.98%	0.84%	2.70%	2.21%	2.50%
Return on Capital Employed (ROCE)	3.00%	3.70%	1.50%	4.60%	4.00%	4.50%
Earnings Yield	4.65%	4.64%	3.87%	4.29%	4.15%	2.91%
FCF Yield	0.45%	0.11%	-3.12%	-1.92%	-0.91%	-1.48%
Dividend Yield	1.72%	2.53%	1.88%	1.96%	2.32%	1.61%
Payout Ratio	63.02%	74.35%	102.89%	63.64%	40.48%	50.09%
Buyback Yield / Dilution	1.39%	-0.02%	-2.40%	-1.74%	-	-
Total Shareholder Return	3.11%	2.51%	-0.52%	0.22%	2.32%	1.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.